Search for Clinical Trial Results
Granulocytopenia - 14 Studies Found
Status | Study |
Terminated |
Study Name: Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia Condition: Severe Chronic Neutropenia Date: 2013-05-08 Interventions: Biological: Filgrastim Zarzio®/Filgrastim HEXAL® solution for injection was provided in prefil |
Completed |
Study Name: GCPGC in Chemotherapy-induced Neutropenia Condition: Chemotherapy Induced Neutropenia Date: 2011-02-06 Interventions:
|
Recruiting |
Study Name: Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia Condition: Neutropenia Date: 2013-08-06 Interventions:
|
Completed |
Study Name: Phase 2 Study of HM10460A or Pegfilgrastim Use for the Management of Neutropenia in Breast Cancer Patients Condition: Neutropenia Date: 2012-10-24 Interventions:
|
Terminated |
Study Name: Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia Condition: Severe Chronic Neutropenia Date: 2009-05-26 Interventions: Drug: Ezatiostat Hydrochloride Starting Dose 2000 mg orally per day in two divided doses with dose to in |
Completed |
Study Name: A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia Condition: Neutropenia Date: 2001-01-18 |
Completed |
Study Name: Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia Condition: Chemotherapy Induced Neutropenia Date: 2013-08-13 Interventions:
|
Completed |
Study Name: Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia Condition: Chemotherapy Induced Neutropenia Date: 2012-01-19 Interventions:
|
Completed |
Study Name: Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutropenia Condition:
Date: 2005-08-29 Interventions:
|
Recruiting |
Study Name: Garlic in Patients With Febrile Neutropenia Condition:
Date: 2005-10-31 Interventions:
|